Orchid Pharma Limited (BOM:524372)
India · Delayed Price · Currency is INR 1,025.80
+19.10 (1.90%)
At close: Oct 7, 2026
Orchid Pharma Market Cap
Orchid Pharma has a market cap or net worth of 52.02 billion as of October 7, 2026. Its market cap has increased by 38.13% in one year.
Market Cap
52.02B
Enterprise Value
54.81B
Revenue
8.52B
Global Rank
n/a
Country Rank
n/a
PE Ratio
173.27
ChartMarket Cap Chart
Since November 3, 2020, Orchid Pharma's market cap has increased from 727.35M to 52.02B, an increase of 7,051.99%. That is a compound annual growth rate of 105.49%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 7, 2026 | 52.02B | 35.14% |
| Dec 31, 2025 | 38.49B | -58.00% |
| Dec 31, 2024 | 91.65B | 153.62% |
| Dec 29, 2023 | 36.14B | 143.20% |
| Dec 30, 2022 | 14.86B | -7.81% |
| Dec 31, 2021 | 16.12B | 223.64% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Nov 3, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Procter & Gamble Health | 88.00B |
| Morepen Laboratories | 74.14B |
| Bliss GVS Pharma | 70.23B |
| Sanofi India | 69.67B |
| FDC Limited | 54.00B |
| Evonile Pharma | 48.59B |
| Gufic Biosciences | 42.17B |
| Kwality Pharmaceuticals | 37.78B |